Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
SGRP vs MMS vs KELYA vs HSII vs CTAS
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Business Services
Staffing & Employment Services
Staffing & Employment Services
Specialty Business Services
SGRP vs MMS vs KELYA vs HSII vs CTAS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Specialty Business Services | Staffing & Employment Services | Staffing & Employment Services | Specialty Business Services |
| Market Cap | $16M | $3.64B | $349M | $1.23B | $68.52B |
| Revenue (TTM) | $147M | $5.32B | $3.09B | $1.21B | $10.79B |
| Net Income (TTM) | $-22M | $373M | $-266M | $37M | $1.90B |
| Gross Margin | 20.7% | 24.6% | 26.3% | 23.3% | 50.2% |
| Operating Margin | -11.7% | 10.8% | -2.8% | 3.0% | 23.0% |
| Forward P/E | — | 7.8x | 11.0x | 16.7x | 34.8x |
| Total Debt | $19M | $1.44B | $159M | $101M | $2.65B |
| Cash & Equiv. | $18M | $260M | $33M | $516M | $264M |
SGRP vs MMS vs KELYA vs HSII vs CTAS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SPAR Group, Inc. (SGRP) | 100 | 99.0 | -1.0% |
| Maximus, Inc. (MMS) | 100 | 92.6 | -7.4% |
| Kelly Services, Inc. (KELYA) | 100 | 64.7 | -35.3% |
| Heidrick & Struggle… (HSII) | 100 | 265.4 | +165.4% |
| Cintas Corporation (CTAS) | 100 | 274.3 | +174.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SGRP vs MMS vs KELYA vs HSII vs CTAS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SGRP is the #2 pick in this set and the best alternative if stability is your priority.
- Beta 0.05 vs KELYA's 1.01
MMS ranks third and is worth considering specifically for valuation efficiency and defensive.
- PEG 0.77 vs CTAS's 2.08
- Beta 0.72, yield 1.8%, current ratio 1.64x
- Lower P/E (7.8x vs 34.8x), PEG 0.77 vs 2.08
KELYA is the clearest fit if your priority is income & stability.
- Dividend streak 5 yrs, beta 1.01, yield 3.2%
- 3.2% yield, 5-year raise streak, vs MMS's 1.8%, (1 stock pays no dividend)
HSII is the clearest fit if your priority is momentum.
- +46.2% vs SGRP's -34.4%
CTAS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 7.7%, EPS growth 16.1%, 3Y rev CAGR 9.6%
- 6.9% 10Y total return vs HSII's 240.0%
- Lower volatility, beta 0.51, Low D/E 56.7%, current ratio 2.09x
- 7.7% revenue growth vs SGRP's -5.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.7% revenue growth vs SGRP's -5.5% | |
| Value | Lower P/E (7.8x vs 34.8x), PEG 0.77 vs 2.08 | |
| Quality / Margins | 17.6% margin vs SGRP's -14.7% | |
| Stability / Safety | Beta 0.05 vs KELYA's 1.01 | |
| Dividends | 3.2% yield, 5-year raise streak, vs MMS's 1.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +46.2% vs SGRP's -34.4% | |
| Efficiency (ROA) | 18.7% ROA vs SGRP's -35.0%, ROIC 25.8% vs -1.8% |
SGRP vs MMS vs KELYA vs HSII vs CTAS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
SGRP vs MMS vs KELYA vs HSII vs CTAS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTAS leads in 2 of 6 categories
HSII leads 1 • KELYA leads 1 • SGRP leads 0 • MMS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CTAS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CTAS is the larger business by revenue, generating $10.8B annually — 73.4x SGRP's $147M. CTAS is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to SGRP's -14.7%. On growth, HSII holds the edge at +14.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $147M | $5.3B | $3.1B | $1.2B | $10.8B |
| EBITDAEarnings before interest/tax | -$16M | $645M | -$54M | $57M | $2.9B |
| Net IncomeAfter-tax profit | -$22M | $373M | -$266M | $37M | $1.9B |
| Free Cash FlowCash after capex | -$18M | $372M | $66M | $132M | $1.8B |
| Gross MarginGross profit ÷ Revenue | +20.7% | +24.6% | +26.3% | +23.3% | +50.2% |
| Operating MarginEBIT ÷ Revenue | -11.7% | +10.8% | -2.8% | +3.0% | +23.0% |
| Net MarginNet income ÷ Revenue | -14.7% | +7.0% | -8.6% | +3.1% | +17.6% |
| FCF MarginFCF ÷ Revenue | -12.0% | +7.0% | +2.1% | +10.9% | +16.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.6% | -4.1% | -100.0% | +14.2% | +9.3% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +6.5% | -2.1% | +16.9% | +11.0% |
Valuation Metrics
Evenly matched — MMS and KELYA each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 12.1x trailing earnings, MMS trades at a 92% valuation discount to HSII's 143.9x P/E. Adjusting for growth (PEG ratio), MMS offers better value at 1.19x vs CTAS's 2.31x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $16M | $3.6B | $349M | $1.2B | $68.5B |
| Enterprise ValueMkt cap + debt − cash | $17M | $4.8B | $475M | $812M | $70.9B |
| Trailing P/EPrice ÷ TTM EPS | -5.25x | 12.10x | -1.34x | 143.93x | 38.65x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.83x | 10.96x | 16.72x | 34.75x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.19x | — | — | 2.31x |
| EV / EBITDAEnterprise value multiple | 14.97x | 6.67x | — | 30.78x | 24.85x |
| Price / SalesMarket cap ÷ Revenue | 0.37x | 0.67x | 0.08x | 1.10x | 6.63x |
| Price / BookPrice ÷ Book value/share | 0.67x | 2.31x | 0.35x | 2.76x | 14.89x |
| Price / FCFMarket cap ÷ FCF | — | 9.93x | 3.06x | 9.88x | 39.00x |
Profitability & Efficiency
CTAS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CTAS delivers a 42.6% return on equity — every $100 of shareholder capital generates $43 in annual profit, vs $-130 for SGRP. KELYA carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMS's 0.86x. On the Piotroski fundamental quality scale (0–9), CTAS scores 9/9 vs SGRP's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -130.0% | +21.8% | -24.6% | +7.3% | +42.6% |
| ROA (TTM)Return on assets | -35.0% | +8.8% | -11.3% | +2.9% | +18.7% |
| ROICReturn on invested capital | -1.8% | +15.1% | -4.0% | +6.0% | +25.8% |
| ROCEReturn on capital employed | -2.8% | +17.4% | -4.3% | +1.1% | +29.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 8 | 5 | 6 | 9 |
| Debt / EquityFinancial leverage | 0.78x | 0.86x | 0.16x | 0.22x | 0.57x |
| Net DebtTotal debt minus cash | $712,000 | $1.2B | $126M | -$415M | $2.4B |
| Cash & Equiv.Liquid assets | $18M | $260M | $33M | $516M | $264M |
| Total DebtShort + long-term debt | $19M | $1.4B | $159M | $101M | $2.7B |
| Interest CoverageEBIT ÷ Interest expense | -7.80x | 4.93x | -12.07x | — | 24.61x |
Total Returns (Dividends Reinvested)
HSII leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTAS five years ago would be worth $19,584 today (with dividends reinvested), compared to $4,113 for SGRP. Over the past 12 months, HSII leads with a +46.2% total return vs SGRP's -34.4%. The 3-year compound annual growth rate (CAGR) favors HSII at 34.9% vs KELYA's -13.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -23.3% | -22.5% | +13.1% | — | -7.8% |
| 1-Year ReturnPast 12 months | -34.4% | +1.1% | -12.2% | +46.2% | -20.1% |
| 3-Year ReturnCumulative with dividends | -32.4% | -11.6% | -34.2% | +145.7% | +51.7% |
| 5-Year ReturnCumulative with dividends | -58.9% | -20.4% | -58.3% | +45.8% | +95.8% |
| 10-Year ReturnCumulative with dividends | -28.9% | +39.7% | -33.0% | +240.0% | +685.0% |
| CAGR (3Y)Annualised 3-year return | -12.2% | -4.0% | -13.0% | +34.9% | +14.9% |
Risk & Volatility
Evenly matched — SGRP and HSII each lead in 1 of 2 comparable metrics.
Risk & Volatility
SGRP is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than KELYA's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HSII currently trades 99.9% from its 52-week high vs SGRP's 48.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | 0.72x | 1.01x | 0.76x | 0.51x |
| 52-Week HighHighest price in past year | $1.41 | $100.00 | $14.94 | $59.05 | $229.24 |
| 52-Week LowLowest price in past year | $0.50 | $60.75 | $7.98 | $39.84 | $165.46 |
| % of 52W HighCurrent price vs 52-week peak | +48.4% | +66.7% | +64.9% | +99.9% | +74.2% |
| RSI (14)Momentum oscillator 0–100 | 63.6 | 35.0 | 63.7 | 77.9 | 37.7 |
| Avg Volume (50D)Average daily shares traded | 55K | 683K | 361K | 0 | 2.2M |
Analyst Outlook
KELYA leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MMS as "Buy", KELYA as "Buy", HSII as "Hold", CTAS as "Hold". Consensus price targets imply 65.0% upside for MMS (target: $110) vs -0.0% for HSII (target: $59). For income investors, KELYA offers the higher dividend yield at 3.23% vs CTAS's 0.88%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | — | $110.00 | $15.00 | $59.00 | $223.40 |
| # AnalystsCovering analysts | — | 16 | 5 | 5 | 30 |
| Dividend YieldAnnual dividend ÷ price | — | +1.8% | +3.2% | +1.0% | +0.9% |
| Dividend StreakConsecutive years of raises | — | 2 | 5 | 1 | 3 |
| Dividend / ShareAnnual DPS | — | $1.19 | $0.31 | $0.61 | $1.49 |
| Buyback YieldShare repurchases ÷ mkt cap | +11.1% | +12.3% | +3.5% | +0.3% | +1.4% |
CTAS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HSII leads in 1 (Total Returns). 2 tied.
SGRP vs MMS vs KELYA vs HSII vs CTAS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SGRP or MMS or KELYA or HSII or CTAS a better buy right now?
For growth investors, Cintas Corporation (CTAS) is the stronger pick with 7.
7% revenue growth year-over-year, versus -5. 5% for SPAR Group, Inc. (SGRP). Maximus, Inc. (MMS) offers the better valuation at 12. 1x trailing P/E (7. 8x forward), making it the more compelling value choice. Analysts rate Maximus, Inc. (MMS) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SGRP or MMS or KELYA or HSII or CTAS?
On trailing P/E, Maximus, Inc.
(MMS) is the cheapest at 12. 1x versus Heidrick & Struggles International, Inc. at 143. 9x. On forward P/E, Maximus, Inc. is actually cheaper at 7. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Maximus, Inc. wins at 0. 77x versus Cintas Corporation's 2. 08x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SGRP or MMS or KELYA or HSII or CTAS?
Over the past 5 years, Cintas Corporation (CTAS) delivered a total return of +95.
8%, compared to -58. 9% for SPAR Group, Inc. (SGRP). Over 10 years, the gap is even starker: CTAS returned +685. 0% versus KELYA's -33. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SGRP or MMS or KELYA or HSII or CTAS?
By beta (market sensitivity over 5 years), SPAR Group, Inc.
(SGRP) is the lower-risk stock at 0. 05β versus Kelly Services, Inc. 's 1. 01β — meaning KELYA is approximately 1825% more volatile than SGRP relative to the S&P 500. On balance sheet safety, Kelly Services, Inc. (KELYA) carries a lower debt/equity ratio of 16% versus 86% for Maximus, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SGRP or MMS or KELYA or HSII or CTAS?
By revenue growth (latest reported year), Cintas Corporation (CTAS) is pulling ahead at 7.
7% versus -5. 5% for SPAR Group, Inc. (SGRP). On earnings-per-share growth, the picture is similar: Cintas Corporation grew EPS 16. 1% year-over-year, compared to -427. 4% for Kelly Services, Inc.. Over a 3-year CAGR, CTAS leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SGRP or MMS or KELYA or HSII or CTAS?
Cintas Corporation (CTAS) is the more profitable company, earning 17.
5% net margin versus -9. 0% for SPAR Group, Inc. — meaning it keeps 17. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTAS leads at 22. 8% versus -2. 2% for SGRP. At the gross margin level — before operating expenses — CTAS leads at 50. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SGRP or MMS or KELYA or HSII or CTAS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Maximus, Inc. (MMS) is the more undervalued stock at a PEG of 0. 77x versus Cintas Corporation's 2. 08x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Maximus, Inc. (MMS) trades at 7. 8x forward P/E versus 34. 8x for Cintas Corporation — 26. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMS: 65. 0% to $110. 00.
08Which pays a better dividend — SGRP or MMS or KELYA or HSII or CTAS?
In this comparison, KELYA (3.
2% yield), MMS (1. 8% yield), HSII (1. 0% yield), CTAS (0. 9% yield) pay a dividend. SGRP does not pay a meaningful dividend and should not be held primarily for income.
09Is SGRP or MMS or KELYA or HSII or CTAS better for a retirement portfolio?
For long-horizon retirement investors, Cintas Corporation (CTAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
51), 0. 9% yield, +685. 0% 10Y return). Both have compounded well over 10 years (CTAS: +685. 0%, KELYA: -33. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SGRP and MMS and KELYA and HSII and CTAS?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SGRP is a small-cap quality compounder stock; MMS is a small-cap deep-value stock; KELYA is a small-cap income-oriented stock; HSII is a small-cap quality compounder stock; CTAS is a mid-cap quality compounder stock. MMS, KELYA, HSII, CTAS pay a dividend while SGRP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.